Avid Bioservices Inc (CDMO)

[biopharm]

Rob Garnick and Bavituximab... love at first sight.

Question: What is it going to take for another pharmcaceutical company to attract the wealth of knowledge and expertise of veteran Rob Garnick away from Genentech? ... All you need is a drug thats better than his first hand knowledge of Avastin

"Peregrine Pharmaceuticals (PPHM) is an early-stage company working toward approval of its first product, a cancer drug.
Navigating the regulatory waters alone can be daunting for a small company. But Peregrine has a seasoned skipper for the important job: Robert Garnick, a 24-year veteran of Genentech. In his two decades at the biotech company (now part of Roche), Garnick oversaw 17 product approvals, including for top-selling drugs Rituxan, Herceptin, Avastin, and Lucentis."

-------------------------------------

http://www.minyanville.com/businessmarkets/articles/peregrine-pharmaceuticals-bavituximab-robert-garnick-steven/6/29/2011/id/35458

------------------------------------

Mr. Garnick tested and developed Avastin and "it is" the sole reason why he is at Peregrine because once he seen the early trial indicators of Bavituximab .... you don't think he realized the data and moa would be a success? He knows the Avastin data... and knows the Bavi data! This is the reasoning behind lining up trial after trial... after trial with Bavi because he is this confident.

I think some investors don't realize that Garnick was the man behind Avastin and this is showtime for Bavi data over the next month or two with possibly the knockout punch for "MOS" data.